- Chr. 1: L-myc, Alzheimer’s (pre-senillin 2)
- Chr. 2: -
- Chr. 3: VHL (3p)
- Chr. 4. Huntington, Achondroplasia (FGFR3), ADPKD (PCKD2)
- Chr. 5: Cri-du-chat (5q-), FAP (APC)
- Chr. 6: Hemochromatosis (HFE)
- Chr. 7: Cystic fibrosis (CFTR, ΔF508), Williams syndrome (elastin)
- Chr. 8: Burkitt (C-myc, N-myc) [t(8;14); t(8;22)]
- Chr. 9: p16 (melanoma), Friedreich’s ataxia (Frataxin-GAA), TS (TSC1), CML (bcr) [t(9;22)]
- Chr. 10: CML [t(9;22)]
- Chr. 11: β-thalassemia (β-globin), bcl-1/cyclin D [t(11;14)], Wilms’ tumor (WT1)
- Chr. 12: -
- Chr. 13: Rb (retinoblastoma, osteosarcoma), BRCA2, Wilson’s (ATP7B)
- Chr. 14: Presenilin-1 (Alzheimer’s), IgH [t(8;14) → Burkitt; t(11;14) → Mantle; t(14;18) → Follicular]
- Chr. 15: Marfan (fibrillin), Prader-Willi & Angelman (15q11), AML M3 (retinoic acid receptor-α) [t(15;17)]
- Chr. 16: α-thalassemia (α-globin), ADPKD (PCKD1), TS (TSC2)
- Chr. 17: NF type 1 (NF1), p53, BRCA1, AML M3 (PML) [t(15;17)]
- Chr. 18: Bcl-2 [t(14;18)], DCC
- Chr. 19: Familial hypercholesterolemia (LDL receptor), ApoE4 (Alzheimer’s → Protective)
- Chr. 20: -
- Chr. 21: B-APP (Alzheimer’s), SOD-1 (ALS)
- Chr. 22: NF type 2 (NF2), DiGeorge (22q11 deletion), CML (abl) [t(9;22)]
- X-linked
- Fragile X syndrome (FMR1 – CGG expansion)
- Menkes kinky hair (ATP7A)
- Bruton (BTK)
- Lesch-Nyhan (HPRT1)
- Wiscott-Aldrich (WASP)
- SCID (IL-2R)
- Duchenne & Becker (Dystrophin)
- Alport syndrome (COL4A5)
- Hemophilia A&B (F VIII & IX)
- Fabry (α-galactosidase A)
- Hunter (iduronate sulfatase)
- G6PD deficiency
- OTC deficiency